CSI Market
Sign In | Register

Acurx Pharmaceuticals inc (ACXP) Quarterly Balance Sheets

Quarterly · GAAP · USD millions
Access ACXP Annual Balance Sheets →
The data below summarizes Acurx Pharmaceuticals inc's balance sheet position from Jun 30 2025 to Jun 30 2026, enabling a period-by-period comparison of financial strength.
View historic periods: Download as CSV:
Download as CSV
Commercial Data Licensing & OEM
Annual commercial subscriptions for corporate use, internal BI systems, management reporting, AI integration, and client-facing platforms
API & Data Feeds
Programmatic access to normalized fundamentals & ratios.
Quarterly Report, GAAP in USD millions
ITEM 		(Jun 30 2026)
(Mar 31 2026) (Dec 31 2025) (Sep 30 2025) (Jun 30 2025)
Assets
Cash & cash equivalent10.66
Cash & Short-term Investments10.00
Accounts receivable0.10
Notes Receivable, Current0.05
Prepaid Expense, Current AS0.23
Total Current Assets11.04
Other Assets, Noncurrent0.00
Total Assets10.98
Liabilities
Accounts Payable and Accrued Liabilities, Current LI2.83
Accrued Liabilities, Current0.03
Other Liabilities, Current0.00
Total Current Liabilities2.83
Total Long-term Debt0.00
Total Liabilities2.83
Stockholders' Equity
Common Stock Value0.00
Additional Paid In Capital Common Stock87.37
Retained Earnings / Accumulated Deficit-79.22
Other Equity0.00
Common Stockholder's Equity8.15
Total Stockholder's Equity8.15
Liabilities & Stockholder's Equity10.98
4 historic quarters locked

Sign in to unlock the full Acurx Pharmaceuticals inc balance sheet history.

Sign In Create Free Account

About Acurx Pharmaceuticals Inc Quarterly Balance Sheet

What this statement shows

This page presents issuer-reported balance sheet data, detailing assets, liabilities, and stockholders equity as reported in SEC 10-Q filings and standardized by CSIMarket. The balance sheet reflects the company's financial position at the end of each reporting period.

Source & verification

Last updated

  • Page updated:
  • Data lineage: SEC filings - XBRL extraction - balance-sheet normalization in the CSIMarket.com financial database.
  • Accession: 0001104659-26-095904

Balance sheet figures represent financial position at specific reporting dates and may be revised in subsequent filings.